prior to now several years, the united kingdom has witnessed a revolution in medical pounds‑loss therapies — in the introduction of semaglutide (Wegovy®) into the developing attractiveness of tirzepatide (Mounjaro®). Now, One more title is drawing interest in both medical and public health and fitness circles: Retatrutide. at present under g